Nightstar Therapeutics plc. (NITE) NASDAQ
$25.41 - (-)
Market Cap: -
As of 06/06/19 04:00 PM EDT. Market closed.
Nightstar Therapeutics plc. (NITE)
NASDAQ
$25.41
- (-)
Market Cap: -
As of 06/06/19 04:00 PM EDT. Market closed.
Add to Portfolio
Nightstar Therapeutics plc is a clinical-stage gene therapy holding company, which engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. Its pipeline includes NSR-REP1, for the treatment of choroideremia; NSR-RPGR, for the treatment of X-linked retinitis pigmentosa; and NSR-BEST1, for the treatment of vitelliform ... read more
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
PRICE CHART FOR NIGHTSTAR THERAPEUTICS PLC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$9.59 - $29.54
Volume
0
Avg. Volume (30 days)
144,620
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
$9.59 - $29.54
Volume
0
Avg. Volume (30 days)
144,620
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR NIGHTSTAR THERAPEUTICS PLC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NIGHTSTAR THERAPEUTICS PLC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Syncona Portfolio Ltd | 10% Owner | Jun 07, 2019 | Option Exercise | $25.50 | 13,203,922 | 336,700,011 | 0 | Jun 11, 2019, 04:30 PM |
| MOTT DAVID M | Director | Jun 07, 2019 | Option Exercise | $25.50 | 6,662,532 | 169,894,566 | 0 | Jun 07, 2019, 04:44 PM |
| New Enterprise Associates 15, L.P. | 10% Owner | Jun 07, 2019 | Option Exercise | $25.50 | 6,662,532 | 169,894,566 | 0 | Jun 07, 2019, 04:43 PM |
| Whitcup Scott M | Director | Jun 07, 2019 | Option Exercise | $25.50 | 74,568 | 1,901,484 | 0 | Jun 07, 2019, 04:41 PM |
| Sundaram Senthil Vel | Chief Financial Officer | Jun 07, 2019 | Option Exercise | $25.50 | 126,886 | 3,235,593 | 0 | Jun 07, 2019, 04:41 PM |
| Robinson Gregory Scott | Chief Scientific Officer | Jun 07, 2019 | Option Exercise | $25.50 | 103,182 | 2,631,141 | 0 | Jun 07, 2019, 04:39 PM |
| Ong Tuyen | Chief Development Officer | Jun 07, 2019 | Option Exercise | $25.50 | 80,479 | 2,052,215 | 0 | Jun 07, 2019, 04:38 PM |
| McArthur James G | Director | Jun 07, 2019 | Option Exercise | $25.50 | 37,237 | 949,544 | 0 | Jun 07, 2019, 04:37 PM |
| Lubner David Charles | Director | Jun 07, 2019 | Option Exercise | $25.50 | 29,124 | 742,662 | 0 | Jun 07, 2019, 04:36 PM |
| Hollowood Christopher J | Director | Jun 07, 2019 | Option Exercise | $25.50 | 13,203,922 | 336,700,011 | 0 | Jun 07, 2019, 04:35 PM |
| FELLOWS DAVID A | Chief Executive Officer | Jun 07, 2019 | Option Exercise | $25.50 | 617,090 | 15,735,795 | 0 | Jun 07, 2019, 04:34 PM |
| Sundaram Senthil Vel | Chief Financial Officer | Apr 01, 2019 | Sale | $25.31 | 391 | 9,896 | 126,886 | Apr 03, 2019, 09:02 PM |
| Robinson Gregory Scott | Chief Scientific Officer | Apr 01, 2019 | Sale | $25.31 | 410 | 10,377 | 103,182 | Apr 03, 2019, 09:01 PM |
| Ong Tuyen | Chief Development Officer | Apr 01, 2019 | Sale | $25.31 | 2,446 | 61,908 | 80,479 | Apr 03, 2019, 09:01 PM |
| FELLOWS DAVID A | Chief Executive Officer | Apr 01, 2019 | Sale | $25.31 | 9,305 | 235,510 | 617,090 | Apr 03, 2019, 09:00 PM |
| FELLOWS DAVID A | Chief Executive Officer | Jan 07, 2019 | Sale | $12.98 | 8,733 | 113,361 | 626,395 | Mar 21, 2019, 09:01 PM |
| Sundaram Senthil Vel | Chief Financial Officer | Jan 07, 2019 | Sale | $12.98 | 406 | 5,270 | 127,277 | Jan 09, 2019, 09:13 PM |
| Ong Tuyen | Chief Development Officer | Jan 07, 2019 | Sale | $12.98 | 2,546 | 33,049 | 82,925 | Jan 09, 2019, 09:12 PM |
| Robinson Gregory Scott | Chief Scientific Officer | Jan 07, 2019 | Sale | $19.98 | 425 | 8,492 | 103,592 | Jan 09, 2019, 09:12 PM |
| FELLOWS DAVID A | Chief Executive Officer | Jan 07, 2019 | Sale | $12.98 | 8,733 | 113,361 | 630,826 | Jan 09, 2019, 09:10 PM |
| Ong Tuyen | Chief Development Officer | Jan 03, 2019 | Sale | $12.00 | 4,070 | 48,840 | 85,471 | Jan 09, 2019, 09:09 PM |
| Robinson Gregory Scott | Chief Scientific Officer | Jan 02, 2019 | Sale | $11.15 | 14,764 | 164,619 | 104,017 | Jan 09, 2019, 09:08 PM |
| Ong Tuyen | Chief Development Officer | Jan 03, 2019 | Sale | $12.00 | 4,070 | 48,840 | 4,070 | Jan 07, 2019, 09:20 PM |
| Robinson Gregory Scott | Chief Scientific Officer | Jan 02, 2019 | Sale | $11.15 | 14,764 | 164,619 | 47,998 | Jan 04, 2019, 12:00 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Syncona Portfolio Ltd | 10% Owner | 06/07/2019 | 336,700,011 |
| MOTT DAVID M | Director | 06/07/2019 | 169,894,566 |
| New Enterprise Associates 15, L.P. | 10% Owner | 06/07/2019 | 169,894,566 |
| Whitcup Scott M | Director | 06/07/2019 | 1,901,484 |
| Sundaram Senthil Vel | Chief Financial Officer | 06/07/2019 | 3,235,593 |
| Robinson Gregory Scott | Chief Scientific Officer | 06/07/2019 | 2,631,141 |
| Ong Tuyen | Chief Development Officer | 06/07/2019 | 2,052,215 |
| McArthur James G | Director | 06/07/2019 | 949,544 |
| Lubner David Charles | Director | 06/07/2019 | 742,662 |
| Hollowood Christopher J | Director | 06/07/2019 | 336,700,011 |
| FELLOWS DAVID A | Chief Executive Officer | 06/07/2019 | 15,735,795 |
| Sundaram Senthil Vel | Chief Financial Officer | 04/01/2019 | 9,896 |
| Robinson Gregory Scott | Chief Scientific Officer | 04/01/2019 | 10,377 |
| Ong Tuyen | Chief Development Officer | 04/01/2019 | 61,908 |
| FELLOWS DAVID A | Chief Executive Officer | 04/01/2019 | 235,510 |
| FELLOWS DAVID A | Chief Executive Officer | 01/07/2019 | 113,361 |
| Sundaram Senthil Vel | Chief Financial Officer | 01/07/2019 | 5,270 |
| Ong Tuyen | Chief Development Officer | 01/07/2019 | 33,049 |
| Robinson Gregory Scott | Chief Scientific Officer | 01/07/2019 | 8,492 |
| FELLOWS DAVID A | Chief Executive Officer | 01/07/2019 | 113,361 |
| Ong Tuyen | Chief Development Officer | 01/03/2019 | 48,840 |
| Robinson Gregory Scott | Chief Scientific Officer | 01/02/2019 | 164,619 |
| Ong Tuyen | Chief Development Officer | 01/03/2019 | 48,840 |
| Robinson Gregory Scott | Chief Scientific Officer | 01/02/2019 | 164,619 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR NIGHTSTAR THERAPEUTICS PLC
LOADING...